Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Proposed Medicaid Rule May Benefit Rheumatologists

Richard Quinn  |  June 21, 2015

The Centers for Medicare & Medicaid Services’ (CMS) first attempt since 2002 to modernize Medicaid reimbursement and other policies could benefit rheumatologists.

The proposed rule would update the “current regulatory framework to reflect the maturity and prevalence of Medicaid managed care delivery systems, promote processes for ensuring access to care and align, where feasible, private and public healthcare coverage programs.”1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

However, the rule doesn’t go far enough to address the growing issues of access to care that beneficiaries face in rural America, according to a Washington, D.C. rheumatologist.

Angus Worthing, MD, a member of the ACR’s Government Affairs Committee and chair of the Rheumatism Society of the District of Columbia’s Public Policy Education Committee, says the proposed rule likely doesn’t “have the teeth to ensure” access for Medicaid beneficiaries.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Health plans will need to certify the adequacy of provider networks every year, and states must ensure that all services are available to beneficiaries,” says Dr. Worthing, who has practiced since 2008 with Arthritis & Rheumatism Associates in Washington, D.C., and Chevy Chase, Md. “Theoretically, both the MCOs [managed care organizations] and the states would be accountable for ensuring access to care, but the specific standards by which these would be judged are not yet known. If changes work, it would be particularly helpful for specialties with shortages, such as rheumatology and especially pediatric rheumatology.”

If enacted, the measures of the proposed rule could help reduce administrative burdens for rheumatologists participating in both Medicaid and Medicare Advantage, Dr. Worthing says. He adds that if rheumatologists are allowed to coordinate such care as referrals, they may “find it easier to get needed diagnostic studies and consults for their rheumatology patients.”

The changes also might “encourage” states to recruit rheumatologists who currently don’t participate in Medicaid.

“This would likely require increased reimbursement, however, and the proposed rule does not include more funding,” he says. “Overall, this could increase access to rheumatologic care and treatment, but it remains to be seen how the states and the District of Columbia will respond.”

Richard Quinn is a freelance author in New Jersey.

References

  1. Centers for Medicare & Medicaid Services. Medicaid and children’s health insurance program (CHIP) programs; Medicaid managed care, CHIP delivered in managed care, medicaid and CHIP comprehensive quality strategies, and revisions related to third party liability. 1 June 2015.

Share: 

Filed under:Billing/CodingPractice Support Tagged with:Access to careCenters for Medicare & Medicaid Services (CMS)MedicaidPediatric RheumatologyReimbursementrheumatolgistrheumatology

Related Articles

    Rheum After 5: Dr. Angus Worthing, the Singing Rheumatologist

    February 16, 2021

    Every Christmas Eve, Angus Worthing, MD, FACP, FACR, his wife, Margaret, and two young children, engage in a sing-off over the phone, competing against a professional quartet comprising his best friend, Doug, Doug’s sister and their parents. Dr. Worthing, a partner at Arthritis & Rheumatism Associates in Washington, D.C., demonstrated his musical talent as a…

    ACR Leads Fight Against Proposed Reimbursement Cuts to E/M Services

    August 7, 2018

    On July 12, the Centers for Medicare and Medicaid Services (CMS) issued its proposed plan for changes to the Medicare Physician Fee Schedule for 2019.1 Citing the need to reduce paperwork and improve patient care, the CMS detailed a number of changes to payments physicians receive from Medicare that could have a significant impact on…

    The Fight Against the Medicare Part B Demonstration Project

    October 28, 2016

    The ACR and 315 other organizations have publicly said savings would not be achieved by the demonstration project and that it will reduce access to care for patients…

    Medicare Telemedicine Underuse May Not Be Due to Reimbursement Policies

    May 11, 2016

    NEW YORK (Reuters Health)—Contrary to previous research, mandating commercial insurance reimbursement of telemedicine was not associated with faster growth in Medicare telemedicine use, according to a newly published study. Dr. Ateev Mehrotra of Harvard Medical School, Boston, and colleagues examined trends in telemedicine utilization by Medicare from 2004–2013 using claims from a 20% random sample…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences